KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Cash from Restructuring (2022 - 2025)

Hims & Hers Health's Cash from Restructuring history spans 3 years, with the latest figure at $932000.0 for Q4 2025.

  • For Q4 2025, Cash from Restructuring changed N/A year-over-year to $932000.0; the TTM value through Dec 2025 reached $5.9 million, changed N/A, while the annual FY2025 figure was $5.9 million, N/A changed from the prior year.
  • Cash from Restructuring for Q4 2025 was $932000.0 at Hims & Hers Health, down from $2.0 million in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $2.0 million in Q3 2025 and bottomed at -$256000.0 in Q3 2022.
  • The 3-year median for Cash from Restructuring is $749000.0 (2023), against an average of $785083.3.
  • The largest YoY upside for Cash from Restructuring was 4645.45% in 2023 against a maximum downside of 58.74% in 2023.
  • A 3-year view of Cash from Restructuring shows it stood at $1.0 million in 2022, then plummeted by 58.74% to $427000.0 in 2023, then soared by 118.27% to $932000.0 in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Cash from Restructuring are $932000.0 (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).